Synthetic method for nicergoline
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 广州普星药业有限公司
- Publication Date
- 2018-04-20
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1
Abstract
Description
technical field
[0001] The invention relates to a synthetic method of nicergoline, which belongs to the technical field of chemical synthesis. Background technique
[0002] Nicergoline, its chemical name is 10α-methoxy-1,6-dimethylergoline-8β-methanyl-5′-bromonicotinate, molecular formula C24H26BrN3O3, molecular weight 484.39, white to slightly yellow crystalline powder, Soluble in ethanol, hardly soluble in water, its structural formula is as structural formula 1:
[0003]
[0004] Nicergoline is mainly used clinically for the treatment of cognitive, emotional and behavioral disorders in the elderly, especially for vascular senile dementia. The pharmacological action of Nicergoline mainly acts on the α-receptor to cause vasodilation and is regarded as a vasoactive drug. In vitro studies, animal experiments and clinical trials in recent years have revealed its wide range of pharmacological effects and clinical application indications.
[0005] The technique of existing...